No significant difference in the CPNE1 mRNA level was observed between NSCLC samples when they were classified according to age and gender; however, significant differences were observed according to lymph node metastasis, smoking habit of the patient and TNM stage (Table 1). This evidence concerns the gene CPNE1 and metastatic malignant neoplasm in the lymph nodes.